Why is Beta Drugs Ltd falling/rising?

As of 29-Oct, Beta Drugs Ltd is experiencing a price increase, currently at 1,896.10, reflecting a change of 24.55 or 1.31% upward. The stock has shown strong performance today, outperforming its sector by 0.57%. Additionally, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. The delivery volume has significantly increased by 293.94% compared to the 5-day average, suggesting rising investor participation. Over the past week, the stock has gained 4.16%, while its year-to-date performance shows a slight decline of 0.65%, contrasting with the Sensex, which has risen by 10.19% year-to-date.
In the broader market context, Beta Drugs Ltd's short-term return of 4.16% over the past week significantly outpaces the Sensex's return of 0.72% during the same period. This indicates that the stock is gaining traction relative to the overall market. Despite a year-to-date decline, the stock's impressive 3-year return of 160.41% compared to the Sensex's 46.48% suggests strong long-term growth potential. Overall, the combination of positive trading indicators and increased investor interest contributes to the stock's rising price.